Research News and Research

RSS

Methyl-Seq and Ultra-Deep Resequencing applications from RainDance Technologies

RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, announced today it will extend the capabilities of its Sequence Enrichment Solution by offering Methyl-Seq and Ultra-Deep Resequencing applications.

23 Oct 2009

Vidacare to release results of validation study on its OnControl Bone Marrow System

Vidacare Corporation has completed an analysis and is releasing the results of a validation study on its OnControl™ Bone Marrow System, the first effort in decades to improve the safety, control, and comfort of bone marrow aspiration and biopsy procedures.

23 Oct 2009

Decision Resources predicts TNF-alpha inhibitors to dominate rheumatoid arthritis treatment

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.

23 Oct 2009

UC Riverside researchers create stable "abnormal N-heterocyclic carbenes"

Researchers at the University of California, Riverside have successfully created in the laboratory a class of carbenes, highly reactive molecules, used to make catalysts - substances that facilitate chemical reactions. Until now, chemists believed these carbenes, called "abnormal N-heterocyclic carbenes" or aNHCs, were impossible to make.

23 Oct 2009

Vasamed partners with BBHOP for peripheral arterial disease research

On Saturday, November 7, 2009 Vasamed Inc., provider of diagnostic technologies that detect peripheral arterial disease in patients with diabetes, will partner with the Black Barbershop Health Outreach Program (BBHOP) in its mission to help African Americans identify the connection between peripheral arterial disease (PAD), diabetes, obesity and hypertension through early detection and referral to appropriate medical resources.

23 Oct 2009

Antidepressant prescriptions are on the rise

A dramatic rise in antidepressant prescriptions issued by GPs has been caused by a year on year increase in the number of people taking antidepressant drugs on a long-term basis, according to researchers from the University of Southampton.

23 Oct 2009

Study: General anesthesia can cause brain injury in immature rats

Studies by researchers at Wake Forest University School of Medicine have shown that blocking the NMDA receptor in immature rats leads to profound, rapid brain injury and disruption of auditory function as the animals mature.

23 Oct 2009

Ambry Genetics awarded CSP status for Agilent's SureSelect Target Enrichment System

Agilent Technologies Inc. and Ambry Genetics today announced that Ambry is the first organization to achieve Certified Service Provider (CSP) status for Agilent's SureSelect Target Enrichment System for next-generation sequencing.

23 Oct 2009

Dig Pink Volleyball Breast Cancer Awareness campaign to raise $1 million in support of breast cancer research

The Side-Out Foundation and its Dig Pink- Volleyball Breast Cancer Awareness campaign will launch a first of its kind clinical trial this month to examine the effects of individualized treatment on patients with metastatic breast cancer.

23 Oct 2009

Yissum Research Development signs long-term multi-project collaboration agreement with Roche

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the University, today announced that it has signed a long-term multi-project research and license collaboration agreement with Roche.

23 Oct 2009

Study reveals benefits of recombinant human C1 inhibitor in treating ischemic brain injury

Biotech company Pharming Group NV announced today publication of a preclinical study showing the benefit of using recombinant human C1 inhibitor (rhC1INH) in ischemic brain injury.

23 Oct 2009

Relationship between cannabis and schizophrenia is controversial

Last year the UK government reclassified cannabis from a class C to a class B drug, partly out of concerns that cannabis, especially the more potent varieties, may increase the risk of schizophrenia in young people. But the evidence for the relationship between cannabis and schizophrenia or psychosis remains controversial.

23 Oct 2009

Families of Spinal Muscular Atrophy and Repligen partner to develop a treatment for SMA

Families of Spinal Muscular Atrophy (FSMA) announced today that it has entered into a groundbreaking exclusive license agreement with Repligen Corporation for the development of a potential treatment of Spinal Muscular Atrophy (SMA).

23 Oct 2009

Brain inflammation not linked to Alzheimer's disease

In a surprising reversal of long-standing scientific belief, researchers at the Mayo Clinic campus in Florida have discovered that inflammation in the brain is not the trigger that leads to buildup of amyloid deposits and development of Alzheimer's disease.

23 Oct 2009

Study finds link between high levels of pesticide exposure and suicidal thoughts

A new study in China has found that people with higher levels of pesticide exposure are more likely to have suicidal thoughts. The study was carried out by Dr Robert Stewart from the Institute of Psychiatry at King's College London together with scientists from Tongde Hospital Zhejiang Province.

23 Oct 2009

Alzheimer's Association appreciates RCN for its generous donation and awareness campaign

RCN Corporation recently donated more than $10,000 towards the Alzheimer's Association, National Capital Area Chapter's Reflections campaign and the nonprofit's signature event, the National Memory Walk. Earlier in the year, the company committed $210,000 in donated cable time for cross-channel spots about local Alzheimer initiatives in 2009.

23 Oct 2009

Researchers discover neurons that precisely keep time in the primate brain

Groups of neurons that precisely keep time have been discovered in the primate brain by a team of researchers that includes Dezhe Jin, assistant professor of physics at Penn State University and two neuroscientists from the RIKEN Brain Science Institute in Japan and the Massachusetts Institute of Technology (MIT).

23 Oct 2009

Physicians' negative attitudes toward obese patients can affect quality of care

Doctors have less respect for their obese patients than they do for patients of normal weight, a new study by Johns Hopkins researchers suggests. The findings raise questions about whether negative physician attitudes about obesity could be affecting the long-term health of their heavier patients.

23 Oct 2009

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.

23 Oct 2009

AEOL 10150 increases regeneration of GI stem cells: NIAID study results

Aeolus Pharmaceuticals, Inc. announced today that recent experiments in preclinical models conducted by the National Institutes of Health’s (NIH), National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear Medical Countermeasure Development program have shown that AEOL 10150 can effectively increase regeneration of gastro-intestinal (GI) stem cells, reduce the severity and duration of diarrhea and improve survival when administered at 24 hours after doses of total-body irradiation that produce the lethal GI syndrome.

23 Oct 2009

Research News and Research

Methyl-Seq and Ultra-Deep Resequencing applications from RainDance Technologies

Vidacare to release results of validation study on its OnControl Bone Marrow System

Decision Resources predicts TNF-alpha inhibitors to dominate rheumatoid arthritis treatment

UC Riverside researchers create stable "abnormal N-heterocyclic carbenes"

Vasamed partners with BBHOP for peripheral arterial disease research

Antidepressant prescriptions are on the rise

Study: General anesthesia can cause brain injury in immature rats

Ambry Genetics awarded CSP status for Agilent's SureSelect Target Enrichment System

Dig Pink Volleyball Breast Cancer Awareness campaign to raise $1 million in support of breast cancer research

Yissum Research Development signs long-term multi-project collaboration agreement with Roche

Study reveals benefits of recombinant human C1 inhibitor in treating ischemic brain injury

Relationship between cannabis and schizophrenia is controversial

Families of Spinal Muscular Atrophy and Repligen partner to develop a treatment for SMA

Brain inflammation not linked to Alzheimer's disease

Study finds link between high levels of pesticide exposure and suicidal thoughts

Alzheimer's Association appreciates RCN for its generous donation and awareness campaign

Researchers discover neurons that precisely keep time in the primate brain

Physicians' negative attitudes toward obese patients can affect quality of care

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

AEOL 10150 increases regeneration of GI stem cells: NIAID study results

A guide to advancing biotherapeutic research eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News